Drug
HSK31858
HSK31858 is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
3
100%
Phase Distribution
0
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
3(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Enrolling by invitation2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 23 (100.0%)
Trials by Status
enrolling_by_invitation267%
completed133%
Recent Activity
0 active trials
Showing 3 of 3
enrolling_by_invitationphase_2
A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Airway Mucus Hypersecretion
NCT06820749
enrolling_by_invitationphase_2
A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Bronchial Asthma
NCT06637254
completedphase_2
A Study of HSK31858 in Participants with Non-Cystic Fibrosis Bronchiectasis
NCT05601778
Clinical Trials (3)
Showing 3 of 3 trials
NCT06820749Phase 2
A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Airway Mucus Hypersecretion
NCT06637254Phase 2
A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Bronchial Asthma
NCT05601778Phase 2
A Study of HSK31858 in Participants with Non-Cystic Fibrosis Bronchiectasis
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3